Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Multimodal magnetic resonance imaging and 18F-L-dihydroxyphenylalanine positron emission tomography in early characterization of pseudoresponse and nonenhancing tumor progression in a pediatric patient with malignant transformation of ganglioglioma treated with bevacizumab.

× No keyword cloud information.

14 in total

1. Ability of (18)F-DOPA PET/CT and fused (18)F-DOPA PET/MRI to assess striatal involvement in paediatric glioma.

Authors: Giovanni Morana; Matteo Puntoni; Maria Luisa Garrè; Michela Massollo; Egesta Lopci; Merhdad Naseri; Mariasavina Severino; Domenico Tortora; Andrea Rossi; Arnoldo Piccardo
Journal: Eur J Nucl Med Mol Imaging Date: 2016-02-25 Impact factor: 9.236

2. Grading and outcome prediction of pediatric diffuse astrocytic tumors with diffusion and arterial spin labeling perfusion MRI in comparison with 18F-DOPA PET.

Authors: Giovanni Morana; Arnoldo Piccardo; Domenico Tortora; Matteo Puntoni; Mariasavina Severino; Paolo Nozza; Marcello Ravegnani; Alessandro Consales; Samantha Mascelli; Alessandro Raso; Manlio Cabria; Antonio Verrico; Claudia Milanaccio; Andrea Rossi
Journal: Eur J Nucl Med Mol Imaging Date: 2017-07-27 Impact factor: 9.236

3. Cerebellar Ganglioglioma in Childhood: Histopathologic Implications for Management During Long-term Survival: A Case Report.

Authors: Koyo Ohno; Yoshiaki Saito; Akiko Tamasaki-Kondo; Atsushi Kambe; Yasushi Horie; Shinsuke Kato; Yoshihiro Maegaki
Journal: Yonago Acta Med Date: 2018-02-05 Impact factor: 1.641

4. Advanced MR imaging and ¹⁸F-DOPA PET characteristics of H3K27M-mutant and wild-type pediatric diffuse midline gliomas.

Authors: Arnoldo Piccardo; Domenico Tortora; Samantha Mascelli; Mariasavina Severino; Gianluca Piatelli; Alessandro Consales; Marco Pescetto; Veronica Biassoni; Elisabetta Schiavello; Michela Massollo; Antonio Verrico; Claudia Milanaccio; Maria Luisa Garrè; Andrea Rossi; Giovanni Morana
Journal: Eur J Nucl Med Mol Imaging Date: 2019-04-27 Impact factor: 9.236

5. Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study.

Authors: Giovanni Morana; Arnoldo Piccardo; Matteo Puntoni; Paolo Nozza; Armando Cama; Alessandro Raso; Samantha Mascelli; Michela Massollo; Claudia Milanaccio; Maria Luisa Garrè; Andrea Rossi
Journal: Neuro Oncol Date: 2015-09-23 Impact factor: 12.300

Multimodal magnetic resonance imaging and 18F-L-dihydroxyphenylalanine positron emission tomography in early characterization of pseudoresponse and nonenhancing tumor progression in a pediatric patient with malignant transformation of ganglioglioma treated with bevacizumab.

1. Ability of (18)F-DOPA PET/CT and fused (18)F-DOPA PET/MRI to assess striatal involvement in paediatric glioma.

2. Grading and outcome prediction of pediatric diffuse astrocytic tumors with diffusion and arterial spin labeling perfusion MRI in comparison with 18F-DOPA PET.

3. Cerebellar Ganglioglioma in Childhood: Histopathologic Implications for Management During Long-term Survival: A Case Report.

4. Advanced MR imaging and ¹⁸F-DOPA PET characteristics of H3K27M-mutant and wild-type pediatric diffuse midline gliomas.

5. Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study.

Review 6. Clinical application of ¹⁸F-DOPA PET/TC in pediatric patients.

Review 7. The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy.

Review 8. Molecular Imaging in Pediatric Brain Tumors.

9. ¹⁸F-FDOPA PET/MRI for monitoring early response to bevacizumab in children with recurrent brain tumors.

Review 10. Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors.

Multimodal magnetic resonance imaging and 18F-L-dihydroxyphenylalanine positron emission tomography in early characterization of pseudoresponse and nonenhancing tumor progression in a pediatric patient with malignant transformation of ganglioglioma treated with bevacizumab.

1. Ability of (18)F-DOPA PET/CT and fused (18)F-DOPA PET/MRI to assess striatal involvement in paediatric glioma.

2. Grading and outcome prediction of pediatric diffuse astrocytic tumors with diffusion and arterial spin labeling perfusion MRI in comparison with 18F-DOPA PET.

3. Cerebellar Ganglioglioma in Childhood: Histopathologic Implications for Management During Long-term Survival: A Case Report.

4. Advanced MR imaging and 18F-DOPA PET characteristics of H3K27M-mutant and wild-type pediatric diffuse midline gliomas.

5. Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study.

Review 6. Clinical application of 18F-DOPA PET/TC in pediatric patients.

Review 7. The use of amino acid PET and conventional MRI for monitoring of brain tumor therapy.

Review 8. Molecular Imaging in Pediatric Brain Tumors.

9. 18F-FDOPA PET/MRI for monitoring early response to bevacizumab in children with recurrent brain tumors.

Review 10. Current Landscape and Emerging Fields of PET Imaging in Patients with Brain Tumors.

4. Advanced MR imaging and ¹⁸F-DOPA PET characteristics of H3K27M-mutant and wild-type pediatric diffuse midline gliomas.

Review 6. Clinical application of ¹⁸F-DOPA PET/TC in pediatric patients.

9. ¹⁸F-FDOPA PET/MRI for monitoring early response to bevacizumab in children with recurrent brain tumors.